key: cord-0279204-3rjsyp8b
authors: Colleluori, Georgia; Graciotti, Laura; Pesaresi, Mauro; Di Vincenzo, Angelica; Perugini, Jessica; Di Mercurio, Eleonora; Caucci, Sara; Bagnarelli, Patrizia; Zingaretti, Cristina M.; Nisoli, Enzo; Menzo, Stefano; Tagliabracci, Adriano; Ladoux, Annie; Dani, Christian; Giordano, Antonio; Cinti, Saverio
title: Visceral Fat Inflammation and Fat Embolism are associated with Lung’s Lipidic Hyaline Membranes in COVID-19 patients
date: 2021-11-01
journal: bioRxiv
DOI: 10.1101/2021.10.30.466586
sha: 1426f7e458652ef02710561df579905057011b8f
doc_id: 279204
cord_uid: 3rjsyp8b

Background Visceral obesity is a critical determinant of severe coronavirus disease-2019 (COVID-19). Methods: In this study, we performed a comprehensive histomorphologic analysis of autoptic visceral adipose tissues (VAT), lungs and livers of 19 COVID-19 and 23 non-COVID-19 subjects. Results Although there were no between-groups differences in body-mass-index and adipocytes size, higher prevalence of CD68+ macrophages in COVID-19 subjects’ VAT was detected (p=0.005) and accompanied by crown-like structures presence, signs of adipocytes stress and death. Consistently, human adipocytes were successfully infected by SARS-CoV2 in vitro and displayed lower cell viability. Being VAT inflammation associated with lipids spill-over from dead adipocytes, we studied lipids distribution employing Oil-Red-O staining (ORO). Lipids were observed within lungs and livers interstitial spaces, macrophages, endothelial cells, and vessels’ lumen, features suggestive of fat embolism syndrome, more prevalent among COVID-19 individuals (p<0.001). Notably, signs of fat embolism were more prevalent among obese (p=0.03) independently of COVID-19 diagnosis, suggesting that such condition may be an obesity complication, exacerbated by SARS-CoV2 infection. Importantly, all infected subjects’ lungs presented lipids-rich (ORO+) hyaline membranes, formations associated with COVID-19-related pneumonia, present only in one control with non-COVID-19 pneumonia. Conclusions This study describes for the first time novel COVID-19-related features possibly underlying the unfavorable prognosis in obese SARS-CoV2-infected-subjects.

Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), 76 responsible for the development of coronavirus disease 2019 , has spread globally 77 resulting in a worldwide health crisis that caused over four million deaths (1). The lung is a crucial 78 target organ not only due to the severe bilateral pneumonia observed in 15-30% of hospitalized 79 patients (2, 3), but also because it is the site from which the infection spreads to blood vessels, heart, 80 gut, brain, and kidneys (4). Published data support interstitial fibrosis with alveolar hyaline membrane 81 (HM) formation as the main underlying histopathologic event responsible for pneumonia and acute 82 respiratory syndrome distress (5, 6). The reasons for HM bilateral expression, histogenesis, and 83 sudden clinical appearance during COVID-19 early stages are not completely understood (7). 84

The severity of COVID-19 is strictly associated with the presence of comorbidities (8); while obesity 85 alone is responsible for 20% of COVID-19 hospitalizations, obesity in combination with type 2 86 diabetes and hypertension accounts for 58% (9). Obesity and impaired metabolic health are in fact 87 strongly associated with COVID-19 unfavorable prognosis and pose also young patients at higher 88 risks (10, 11). Importantly, visceral obesity increases the risk of COVID-19-related complications, 89 independently of age, gender, body mass index (BMI), total and subcutaneous adipose tissue areas 90 (12) (13) (14) (15) . Visceral obesity is in fact strongly associated with chronic low-grade inflammation, blood 91 hypercoagulability, impaired metabolic health, and higher risk of cardiovascular events, all risk 92 factors for COVID-19 severity (8, 11, (15) (16) (17) . Visceral adipose tissue (VAT) excessive expansion is 93 paralleled by adipocytes hypertrophy, death, and lipids spill-over, phenomena resulting in 94 macrophages infiltration, crown-like structures (CLS) development and inflammation, in turn 95 contributing to the obesity-related complications (18) (19) (20) . The elevated adipocytes ACE2 expression 96 in obesity (21), receptor exploited by SARS-CoV2 for cell entry, has been often speculated as a 97 possible pathophysiological mechanism responsible for obesity-related COVID-19 severity (8, 22, 98 23) . However, although obesity has been strongly associated with COVID-19 severity (but not higher 99 infection rates), original articles comprehensively analyzing adipose tissue samples belonging to 100 dilutions. The same antibodies were used to detect the virus on infected VeroE6 at dilution: 1:1000 152 for nucleocapsid protein and 1:100 for the spike protein. To assess antibody specificity, negative 153 control in which primary antibody was omitted were always included in each set of reaction. Tissue 154 sections were observed with a Nikon Eclipse E800 light microscope. For morphometric purposes, for 155 each paraffin section, 10 digital images were acquired at 20X magnification with a Nikon DXM 1220 156 camera. CD68 positive macrophages widespread in VAT parenchyma and those organized to form 157 CLS were counted in all images. For each subject the number of total macrophages and the density 158 of CLS/10⁴ adipocytes were counted with the ImageJ morphometric program (RRID:SCR_003070). 159

Adipocytes' area was measured in all patients by counting 100 adipocytes for each paraffin tissue 160 section using ImageJ. 161

For Oil Red-O (ORO) staining samples were cryoprotected in 30% sucrose overnight, embedded in 163 the optimal cutting temperature (OCT) compound medium, and then sliced to obtain 7 mthick 164 cryosections by Leica CM1900 cryostat (Vienna, Austria). ORO staining was then performed on 165 lungs (43) and liver (n=9) cryosections. In brief, dried cryosections were first placed in 60% 166 isopropanol, then in filtrated Oil-Red O working solution (15 minutes at room temperature) and 167 briefly washed again in 60% isopropanol and lastly in H2O. Tissue slices were then counterstained 168 with hematoxylin and cover with a coverslip using Vectashield mounting medium (Vector 169 Laboratories). Lung and liver tissues organization and morphology were also studied by hematoxylin 170 & eosin (H&E) staining on paraffin sections. Lung's hyaline membranes presence and 171 characterization were performed on paraffin sections by H&E, periodic acid-Schiff and Masson 172 trichome staining. 173

For ultrastructural analyses, 3-mm thick VAT (n=4), lung (n=7) and liver (n=1) samples were further 175 fixed in 2% glutaraldehyde-2% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) and post-fixed 176 in Osmiun Tetroxide 1% then embedded in epoxy resin for TEM studies as described elsewhere (38) . 177

Cell pellets from the in vitro studies were similarly fixed in 2% glutaraldehyde-2% paraformaldehyde 178 in 0.1 M phosphate buffer (pH 7.4) for one hour at room temperature and then embedded in epoxy-179 resin. A MT-X ultratome (RMC; Tucson) was used to obtained ultrathin sections (~70 nm). 180

Ultrastructural characterization was performed on all samples using a CM10 Philips transmission 181 electron microscope (Philips, Eindhoven, The Netherlands, http:// www.usa.philips.com). 182

Between-group comparisons for linear and categorical variables were determined by unpaired two-184 tailed Student's t-test and Chi-square test, respectively. Group differences were considered significant 185 when p<0.05. Data in graph are expressed as mean ± SEM. Statistical analyses were performed with 186 Prism 6.0 (GraphPad Software Inc., La Jolla, CA) and IBM SPSS Statistics Data Editor (v.24). 187

Vero E6 cells were cultured in Dulbecco's modified Eagle medium (DMEM, Euroclone, Milano, 189 Italy), supplemented with 10% fetal calf serum (FCS Euroclone) and antibiotics/antimycotic (100 190 U/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B) at 37°C, 5% CO2 in a 191 humidified atmosphere (90%), as described previously (39). Cells were maintained in 75 cm 2 tissue 192 culture flasks. The day before infection, a confluent monolayer was trypsinized, and 1,5 x 10 6 cells 193 were seeded in every 8 flasks (25 cm 2 ). Confluent monolayers were infected with SARS CoV-2 194 (78952 isolate, accession no. MT483867) (40) at a multiplicity of infection (MOI) of 3.29•10 5 . After 195 2 hours of incubation, the medium containing the inoculum was removed, the cells were washed 196 twice, and fresh medium was added, which was collected after 6, 12, 24 and 48 h for viral genome 197 quantification and replaced with 2 ml of fresh culture medium to allow scraping of the infected 198 monolayer. Uninfected cell monolayer controls were treated as infected ones. Cell suspensions (2ml) 199

were subsequently centrifuged at 800 rpm for 5 minutes. Aliquots of infected supernatants, collected 200 as above, were analyzed using RT-qPCR assay as described elsewhere (40). Briefly, 5 µl of RNA 201 extracted from 140 µl of infected supernatants were run together with a calibration curve, obtained 202 from 10-fold dilutions of a standard plasmid certified and quantified by a supplier (2019-nCoV 203 Positive Control, nCoVPC, 85 IDT) and negative control, applying a protocol described by CDC 204 (https://www.fda.gov/media/134922/download). 205

In vitro studies on hMADS 206

Ethical Approval: Human adipocytes progenitors -Aps-(hMADS cells) were isolated from adipose 207 tissue, as surgical scraps from surgical specimen of various surgeries of young donors, with the 208 informed consent of the parents. All methods were approved and performed in accordance with the 209 guidelines and regulations of the Centre Hospitalier Universitaire de Nice Review Board. 210

Cell Differentiation-hMADS cells were maintained and differentiated as previously described (41). 211

They will be further referred to as hMADS-adipocytes. They were routinely tested for the absence of 212 mycoplasma. Treatments and biological assays were carried out in duplicates on control or 213 differentiated hMADS cells from day 4 to 18. 214

Gene expression analysis-Total RNA was extracted using the TRI-Reagent kit (Euromedex, 215 Soufflweyersheim, France) and reverse transcription (RT) was performed using MMLV reverse 216 transcriptase (Promega, Charbonnieres, France), as recommended by the manufacturers. All primer 217 sequences are described in the supplementary section. Real-time PCR assays were run on an ABI 218 Prism One step real-time PCR machine (Applied Biosystems, Courtaboeuf, France). Normalization 219 was performed using 36B4 as a reference gene. Quantification was performed using the comparative 220 subjects with a BMI≥25.0 kg/m 2 were observed in VAT samples (Fig.1A) . However, although there 288 were no between-groups differences in BMI and VAT adipocytes size (Fig.1B) , higher prevalence of 289 CD68+ macrophages (Fig.1C ) and a trend for higher presence of CLS (Fig.1D) were evidenced in 290 COVID-19 patients compared to controls, suggesting higher SARS-CoV2-induced VAT 291 inflammation. Other inflammatory cells were represented mainly by lymphocytes, but their number 292 was negligible in all investigated cases. 293

We then assessed whether the higher VAT inflammation in COVID-19 patients was 294 associated with adipocytes death. Perilipin 1 (PLIN1) immunohistochemistry is a reliable method for 295 identification and quantification of dead adipocytes (18, 24) . However, in the present study, all 296 samples display PLIN1 negative adipocytes, probably due to the autoptic nature of specimens. We 297 hence performed a morphologic and ultrastructural study to assess VAT adipocytes stress and death. 298

Electron microscopy showed signs of adipocytes death in proximity of CLS in both COVID-19 and 299 controls subjects with a BMI≥25 kg/m 2 , a finding consistent with previous studies documenting 300 obesity-related adipocytes death (25). However, COVID-19 subjects VAT was rich in stressed and 301 dead adipocytes (Fig. 1E -F) also in areas lacking CLS and seemingly normal at light microscopy. In 302 line with the observed widespread death, cell remnants were evidenced in closed proximity of dying 303 adipocytes, while free lipid droplets were often found in fat interstitial spaces ( Fig.1F and 1G) . 304

Notably, large lipid vacuoles were also observed: i. inside endothelial cells belonging to capillaries 305 adjacent to free lipid droplets ( Fig.1H and Fig.1I) ; ii. extruding from endothelial cells into the 306 capillary lumen (Fig.1I) ; iii. in the lumen of VAT capillaries (Fig.1J) ; iv. in macrophages near 307 interstitial free lipid droplets (data not shown). In addition, several clusters of lipid-rich structures 308 were found into the lumen of venules belonging to mesenteric fat samples (Fig.1K ). In summary, the 309 in-depth ultrastructural analyses of VAT autoptic samples belonging to COVID-19 subjects revealed 310 the widespread presence of free lipid droplets (likely deriving from dead adipocytes) inside the 311 capillary lumen, all features underlining a condition able to generate fat embolism syndrome (FES) 312 (26). 313

We then aimed at assessing whether the observed VAT alterations were associated with 314 SARS-CoV2 local-tissue presence or if they were a consequence of the systemic infection. Although 315 SARS-CoV2 ability to infect human adipose tissue has been frequently speculated (8, 12, 17, 22) , 316 direct evidence of such phenomenon has not been documented in the literature (15) VeroE6 cells ( Fig. 2A) were found in the cytoplasm of stressed adipocytes (Fig.2B) . Furthermore, 321 the presence of ribosome-like clusters, described in virus-infected cells (28) was evidenced in both, 322 visceral adipocytes belonging to COVID-19 subjects ( Fig. 2C and 2D ) and SARS-CoV2-infected 323 VeroE6 (Fig. 2E ). In addition, confronting cisternae, ribosome lamella complex and annulate 324 lamellae, typical of several pathologic conditions including virus infection (29), were observed in 325 VAT adipocytes belonging to COVID-19 subjects (Suppl. Fig.1A -D) and in SARS-CoV2 infected 326 VeroE6 (Suppl. Fig.1E ), but not in uninfected controls. Next, to provide direct evidence of SARS-327

CoV2 ability to infect human adipocytes, leading to cell stress and death, we infected differentiated 328 human multipotent adipocytes (hMADS) (Fig. 2F-H) and studied SARS-CoV2 kinetics in vitro. The 329 growth kinetics of SARS-CoV2 was determined as viral load (copies/ml) in the supernatants collected 330 after 24-, 48-, 72-and 96-hours post-infection (Fig. 2F) . While SARS-CoV2 genomic RNA was 331 detectable in both, differentiated and undifferentiated hMADS at the first timepoints post-infection 332 (24 and 48 h), it could be detected only in mature adipocytes at later timepoints (72 and 96 h) (Fig.  333   2F) . Consistently, SARS-CoV2 genomic RNA was also detected in the hMADS adipocytes pellet 334 after 96-hours of infection (Fig. 2G) . Importantly, infected hMADS adipocytes displayed lower cell 335 viability (Fig. 2H) , higher prevalence of pyknotic nuclei (Fig. 2I-K) and smaller lipid droplet size -336 suggestive of cell delipidation and stress-compared to uninfected controls (Fig. 2L) Lung's fat embolism was not exclusive of, but more prevalent among COVID-19 subjects as 356 compared to controls (100% vs 53%; p<0.001). Signs of fat embolism were in fact more prevalent 357 among individuals with obesity than in those with a BMI≤30 kg/m 2 (93% vs 63%, p=0.03), 358 independently of COVID-19 diagnosis. Consistently, all subjects with type 2 diabetes (T2DM) had 359 fat embolism. Of note, electron microscopy observation revealed several structures with size and 360 morphology compatible with those of SARS-CoV2 viruses (6) in pneumocytes, endothelial cells and 361 macrophages, the last of which displayed disseminated, dilated endoplasmic reticulum denoting 362 cellular stress (25, 30) and signs of virus presence only in COVID-19 subjects (Fig. 3G-H) . 363 Furthermore, we also evidenced also two virions at early and late stages of reproductive cycle (31) 364 into the dilated endoplasmic reticulum (Fig. 3H ) comparable with those revealed in infected VeroE6 365 in Fig. 3I . Importantly, septal capillaries very often contained large amounts of fibrin, with some of 366 them lining by fibrin-thrombotic material only in COVID-19 individuals' lungs (data not shown). 367

Several Weibel-Palade bodies, signs of activated coagulative phenomena (29), were observed also in 368 capillary endothelial cells belonging to COVID-19 subjects (data not shown). 369

Unexpectedly, the ORO technique evidenced also positively stained alveolar structures 370 reminiscent of hyaline membranes (Fig. 4A) . The presence of hyaline membranes was then confirmed 371 by hematoxylin and eosin, by Mallory and periodic acid-Schiff staining (data not shown). All 372 COVID-19 subjects presented lung's hyaline membranes, which were on the other side detected only 373 in one control subject (BMI 21.3 kg/m 2 ) who died of pneumonia (p<0.0001). Interestingly, this last 374 subject displayed fainted lung's hyaline membrane positivity for ORO staining, suggesting a lower 375 lipidic composition. This finding is consistent with other reports describing hyaline membrane 376 presence in pneumonia (7). Importantly, ORO positive lipid droplets and lipid-rich macrophages were 377 often enclosed into the hyaline membranes lining the alveolar surface (Fig. 4B-D) . Several aspects 378 suggesting a direct role of embolic fat in hyaline membranes formation were observed. Specifically, 379 free lipid droplets occupying the alveolar space and lining and spreading on the alveolar surface were 380 observed ( Fig. 4E-H) . The presence of lung's hyaline membranes of lipidic nature was associated 381 with visceral adipose tissue inflammation (8.0±5.4 vs 3.7±1.8 CD68+ macrophages/10 adipocytes in 382 subjects with and without hyaline membranes, respectively) and exclusive of COVID-19 cases 383 (Suppl. Fig. 2) . 384

Lastly, since the embolic material from abdominal visceral tissues should necessarily pass 385 through the liver parenchyma to reach the lung, we exploited the ORO staining technique to study 386 liver samples belonging to 9 COVID-19 and 8 control subjects. Liver autoptic samples showed focal, 387 macrovescicular steatosis with lipid droplets of very variable size (Suppl. Fig. 3A ), consistent with 388 other studies conducted on COVID-19 subjects (32). In particular, signs consistent with fat embolism, 389

i.e., presence of free lipid droplets into hepatic sinusoids (Suppl. Our study provides the first evidence of higher local VAT inflammation among COVID-19 408 subjects, independently of obesity status and support COVID-19-induced exacerbation of obesity-409 related inflammation, a novel finding consistent with studies reporting higher systemic inflammation 410 among infected patients (17). Adipocyte's inflammation is associated with adipocytes stress, death 411 and lipids release in the extracellular space (18, 19, 24, 25) . We hence studied adipocytes features by 412 TEM and revealed the presence of the typical signs of cellular stress, together with clear features of 413 lipids' spill-over from suffering adipocytes. Lipids were in fact detected in the extracellular space, 414 inside endothelial cells, inside the capillary lumen, and extruding from endothelial cells into the 415 capillary lumen, all features indicative of fat embolism. 416

Although virus like structures were evidenced by TEM in the same VAT depots, the lack of 417 SARS-CoV2 detection by qPCR did not allow us to conclude that such inflammation, cellular stress 418 and death were all related to the presence of this virus. It is in fact possible that the described VAT 419 features were secondary to the systemic inflammation induced by COVID-19 or due to the presence 420 of different viruses within the depot. On the other side, we were able to demonstrate that SARS-CoV2 421 can infect human adipocytes even though neither adipocytes, nor adipocytes progenitors gathered all 422 the known molecular requirements for the virus entry (expression of all known virus proteases and 423 receptors). This set of data is in part consistent with other findings and suggest that additional, not 424 yet characterized, receptors and proteases may be exploited for this purpose (15, 33) . 425

Considering the widespread lipid droplets presence in the capillary lumen of VAT and 426 considering our preliminary data (22), we studied lipid distribution in lung and liver samples and 427 confirmed the presence of fat embolism. Interestingly, we noticed similar lipid-like structures also in 428 lung's images from other reports on COVID-19 subjects, reason for which we believe it is worth 429 performing further in-depth analyses on available samples (5, 6, 34). 430

Fat embolism was prevalent among, but not exclusive of, subjects with COVID-19; it was in 431 fact detected also among subjects with obesity independently of SARS-CoV2 infection. These data 432

are not surprising given that adipocyte's death and release of lipids are both phenomena occurring in 433 obesity (18, 24, 25) . This finding provides the first evidence pointing out fat embolism as a 434 complication of obesity (and obesity plus T2DM), determined by adipocytes death and possibly 435 exacerbated by the COVID-19-induced inflammatory status. Importantly, studying lung's lipid 436 distribution, we unexpectedly revealed the presence of lipidic hyaline membranes, formation strongly 437 contributing/associated to COVID-19 related interstitial fibrosis and pneumonia (6). Hyaline 438 membranes were present in all COVID-19 subjects and in only one control who died for pneumonia, 439 a finding consistent with other reports describing hyaline membrane presence in pneumonia (7) 

Predictors of mortality in 490 patients with severe COVID-19 pneumonia -a retrospective study

Clinical features of patients infected 493 with 2019 novel coronavirus in Wuhan

Pathological findings of COVID-19 497 associated with acute respiratory distress syndrome

Histopathology and 499 ultrastructural findings of fatal COVID-19 infections in Washington State: a case series

The aging 502 lung: Physiology, disease, and immunity

Global pandemics interconnected -obesity, 504 impaired metabolic health and COVID-19

Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A 507 Comparative Risk Assessment Analysis

Factors 509 associated with COVID-19-related death using OpenSAFELY

Nonrespiratory Complications and Obesity in Patients Dying with COVID-19 513 in Italy

Computed Tomography 515 Highlights Increased Visceral Adiposity Associated With Critical Illness in COVID-19. 516 Diabetes Care

Visceral fat shows 518 the strongest association with the need of intensive care in patients with COVID-19. 519 Metabolism

The role of 521 visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional 522 pilot study in Germany

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the 524 beginning

Body 526 Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission

Invasive Mechanical Ventilation, and Death -United States

Poor Metabolic Health Increases COVID-19-Related Mortality in 530 the UK Biobank Sample. Front Endocrinol (Lausanne)

Adipocyte death defines 532 macrophage localization and function in adipose tissue of obese mice and humans

Inflammation, metaflammation and immunometabolic disorders

Aging, obesity, sarcopenia and the effect of diet and exercise 537 intervention

ACE2 is 539 expressed in mouse adipocytes and regulated by a high-fat diet

COVID-19 and fat embolism: a 542 hypothesis to explain the severe clinical outcome in people with obesity

Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With Coronavirus SARS-546

Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia 547 Management in COVID-19

Dead 549 adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically 550 obese mice

Muscle and 552 adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and 553 nondiabetic obese patients: effects of bariatric surgery

Nontraumatic Multiple-Organ Fat 555 Embolism: An Autopsy Case and Review of Literature

Viral mapping 558 in COVID-19 deceased in the Augsburg autopsy series of the first wave: A multiorgan and 559 multimethodological approach

Ultrastructural Pathology of the Cell and Matrix

Obese adipocytes 564 show ultrastructural features of stressed cells and die of pyroptosis

Coronaviruses post-SARS: update on replication and pathogenesis

Hepatic pathology 569 in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and 570 virologic data

Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell

Diffuse 575 alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically 576 Indistinguishable from Other Causes of DAD

Lung Metabolic 578 Activation as an Early Biomarker of Acute Respiratory Distress Syndrome and Local Gene 579 Expression Heterogeneity

Istituto Superiore di Sanità-Research ethics during the COVID-19 pandemic: 583 observational and, in particular, epidemiological studies

Morphologic techniques for the 585 study of brown adipose tissue and white adipose tissue

MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited 588 by cyclosporin A or interferon-alpha treatment

590 Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel 591 Sequencing

The human adipose tissue is a 593 source of multipotent stem cells

Measurement of cell death in mammalian cells

Light microscopy (LM): representative immunohistochemistry of visceral adipose tissue 628 infiltrated by CD68+ macrophages (in brown); inset shows an enlargement of the squared area

C) number of CD68+ macrophages per 10 4 adipocytes, and 630 (D) number of crown-like structures (CLS) per 10 4 adipocytes in COVID-19 vs control subjects

Transmission electron microscopy (TEM): normal adipocyte 632 adjacent to a stressed adipocyte showing dilated endoplasmic reticulum (arrows). (F) TEM: dead 633 adipocytes and interstitial free lipid droplets (*); arrows indicate adipocytes remnants. (G) TEM: free 634 lipid droplets of variable size were frequently

Enlargement of squared area in G showing lipid droplets inside endothelial cells (arrows). (I) TEM: 636 enlargement of a capillary from a COVID-19 subject showing a lipid droplet extruding into the 637 capillary lumen (arrow), note the abundant Weibel-Palade bodies denoting increased blood 638 hypercoagulability (arrowheads)

K) LM: mesenteric fat sample showing lipid-rich embolic material in a vein (squared 640 area, enlarged in inset). Morphometric data are expressed as means±SE

A=100 m, E=0,8 m, F=2,5 m, G=10 m, H=3 m, I=1,5 m, J=0,8 m, K=  m

Figure 2. SARS-CoV2 in visceral adipose tissue and hMADS 644 (A) Transmission electron microscopy (TEM): Vero E6 infected cell showing several virions into the 645 rough endoplasmic reticulum (RER), some indicated by arrows

Inset: enlargement of squared area. (C) TEM: VAT of a COVID-648 19 subject showing an adipocyte (Ad) with two large ribosome-like clusters (dotted lines) in the 649 cytoplasm. (D) Enlargement of squared area in C showing ribosome-like cluster and a virion-like 650 structure

SARS-CoV2 infection kinetic in 652 undifferentiated and differentiated hMADS. SARS-CoV2 genomic RNA detected in the supernatant 653 at different timepoints, expressed as copies (cps)/ml. (G) SARS-CoV2 quantification in supernatant 654 and cell pellets of hMADS infected cells

uninfected hMADS adipocytes shows lower cell viability in the first compared to the last at 24-and 656 96-hours post-infection (p<0.05). (I) Percentage of pyknotic nuclei in hMADS adipocytes at 96h

post-infection compared to uninfected controls (p<0.05). (J) Hoechst nuclear staining showing 658 pyknotic nuclei (arrows) in differentiated hMADS adipocytes. (K) Lipid droplets average area

Expression 660 of putative SARS-CoV2 receptors (L) or proteases (M) assessed by RT-qPCR and normalized for the 661 expression of 36B4 mRNA. Expressions were measured in cells that received (red bars) or did not 662 receive (blue bars) the differentiation cocktail for the indicated number of days. The means ± SEM 663 were calculated from three independent experiments (ACE2, BSG, NRP1, CSTL) or four independent 664 experiments (FURIN, DPP4)

Scale Bar: A, B =200 nm, C=500 nm D=100 nm E=180 nm, F=120 m, G=70 m

Embolic lipid droplets and SARS-CoV2 virions in lung of COVID-19 subjects

Light microscopy (LM): representative histochemistry for fat (Oil-Red O) showing the lipid nature 669 of vacuoles (orange-red) in the vascular lumen (arrows) and lung septa of different

Large free lipid droplets (yellow) are 671 evident into the capillaries lumen in alveolar septa (arrows). (F) Transmission electron microscopy 672 (TEM): showing lipid droplet (LD) into an alveolar septum mixed with erythrocytes. (G) TEM: 673 alveolar macrophage (M) in a COVID-19 subject. Note: diffuse dilated rough endoplasmic reticulum 674 (RER) denoting cellular stress (arrows) (H) TEM: enlargement of the squared area in G showing two 675 virions at stages 1-2

to 5) stages of reproductive cycle of SARS-CoV2 virions in VeroE6 infected cells

Oil-Red O-stained lung of COVID-19 subjects showing hyaline membranes 681 morphology and composition 682 (A) Light microscopy (LM): hyaline membranes lining alveolar surfaces (arrows) at low 683 magnification. (B) LM: enlargement of squared area in A showing the microvacuolar nature of ORO+ 684 hyaline membrane (blue arrow)

LM: ORO+ large, free lipid vacuole lining the alveolar surface (red arrow) near a 688 hyaline membrane (blue arrow). (F) TEM: free lipid droplet lining the alveolar surface composed by 689 pneumocytes type II (PT2) with classic surfactant granules (arrow). (G) LM: ORO+ lipid vacuole 690 spreading on the alveolar surface (possible early stage of lipid diffusion). (H) LM: ORO+ lipid 691 vacuoles possibly contributing to hyaline membranes development (later stage). Scale Bar: A and E= 692 50 m

1: Representative transmission electron microscope images of visceral adipose tissue 695 from COVID-19 subject

RER confronting cisternae in endothelial cell comparable to those found in 698 infected VeroE6 cells (compare with E). (C) Ribosome-lamella complex in a capillary (arrow, 699 enlarged in upper inset). (D) Annulate lamellae found in a lung's macrophage. (E) RER confronting 700 cisternae in SARS-CoV2 -infected Vero-E6 cell. (F) Light microscopy of differentiated hMADS 701 extruding lipid-like material. (G) Toluidine staining of an hMADS cell extruding a lipid vacuole 702 (resin-embedded). (H) Quantitative analyses of the

SARS-CoV2 infected and uninfected hMADS. Ad: adipocyte. Scale bar: A=0,8 m, B=120 nm

Schematic representation of the prevalence of fat embolism (FE) and lipidic 706 hyaline membranes (HM) in the study population

Number of patients for each category is reported in parenthesis

Fat embolic features in liver of three different COVID-19 subjects with 710 documented lung fat embolism. (A) Focal, macrovescicular steatosis evidenced by Oil-Red O 711 staining (ORO). (B) Several ORO+ lipid droplets into sinusoids (arrows). (C) Portal area 712 enlargement of subject shown in B